BACKGROUND: Mutations in the GJB2 gene are the most common cause of nonsyndromic recessive hearing loss in China. In about 6% of Chinese patients with severe to profound sensorineural hearing impairment, only monoallelic GJB2 mutations known to be either recessive or of unclear pathogenicity have been identified. This paper reports the prevalence of the GJB2 IVS1+1G>A mutation in a population of Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2. METHODS: Two hundred and twelve patients, screened from 7133 cases of nonsyndromic hearing loss in China, with monoallelic mutation (mainly frameshift and nonsense mutation) in the coding region of GJB2 were examined for the GJB2 IVS1+1G>A mutation and mutations in the promoter region of this gene. Two hundred and sixty-two nonsyndromic hearing loss patients without GJB2 mutation and 105 controls with normal hearing were also tested for the GJB2 IVS1+1G>A mutation by sequencing. RESULTS: Four patients with monoallelic mutation in the coding region of GJB2 were found carrying the GJB2 IVS1+1G>A mutation on the opposite allele. One patient with the GJB2 c.235delC mutation carried one variant, -3175 C>T, in exon 1 of GJB2. Neither GJB2 IVS1+1G>A mutation nor any variant in exon 1 of GJB2 was found in the 262 nonsyndromic hearing loss patients without GJB2 mutation or in the 105 normal hearing controls. CONCLUSION: Testing for the GJB2 IVS 1+1 G to A mutation explained deafness in 1.89% of Chinese GJB2 monoallelic patients, and it should be included in routine testing of patients with GJB2 monoallelic pathogenic mutation.
BACKGROUND: Mutations in the GJB2 gene are the most common cause of nonsyndromic recessive hearing loss in China. In about 6% of Chinese patients with severe to profound sensorineural hearing impairment, only monoallelic GJB2 mutations known to be either recessive or of unclear pathogenicity have been identified. This paper reports the prevalence of the GJB2 IVS1+1G>A mutation in a population of Chinese hearing losspatients with monoallelic pathogenic mutation in the coding region of GJB2. METHODS: Two hundred and twelve patients, screened from 7133 cases of nonsyndromic hearing loss in China, with monoallelic mutation (mainly frameshift and nonsense mutation) in the coding region of GJB2 were examined for the GJB2 IVS1+1G>A mutation and mutations in the promoter region of this gene. Two hundred and sixty-two nonsyndromic hearing losspatients without GJB2 mutation and 105 controls with normal hearing were also tested for the GJB2 IVS1+1G>A mutation by sequencing. RESULTS: Four patients with monoallelic mutation in the coding region of GJB2 were found carrying the GJB2 IVS1+1G>A mutation on the opposite allele. One patient with the GJB2c.235delC mutation carried one variant, -3175 C>T, in exon 1 of GJB2. Neither GJB2 IVS1+1G>A mutation nor any variant in exon 1 of GJB2 was found in the 262 nonsyndromic hearing losspatients without GJB2 mutation or in the 105 normal hearing controls. CONCLUSION: Testing for the GJB2 IVS 1+1 G to A mutation explained deafness in 1.89% of Chinese GJB2 monoallelic patients, and it should be included in routine testing of patients with GJB2 monoallelic pathogenic mutation.
Authors: S A Wilcox; K Saunders; A H Osborn; A Arnold; J Wunderlich; T Kelly; V Collins; L J Wilcox; R J McKinlay Gardner; M Kamarinos; B Cone-Wesson; R Williamson; H H Dahl Journal: Hum Genet Date: 2000-04 Impact factor: 4.132
Authors: Ignacio del Castillo; Manuela Villamar; Miguel A Moreno-Pelayo; Francisco J del Castillo; Araceli Alvarez; Dolores Tellería; Ibis Menéndez; Felipe Moreno Journal: N Engl J Med Date: 2002-01-24 Impact factor: 91.245
Authors: Xue Zhong Liu; Xia Juan Xia; Xiao Mei Ke; Xiao Mei Ouyang; Li Lin Du; Yu He Liu; Simon Angeli; Fred F Telischi; Walter E Nance; Thomas Balkany; Li Rong Xu Journal: Hum Genet Date: 2002-08-16 Impact factor: 4.132
Authors: M J Houseman; L A Ellis; A Pagnamenta; W L Di; S Rickard; A H Osborn; H H Dahl; G R Taylor; M Bitner-Glindzicz; W Reardon; R F Mueller; D P Kelsell Journal: J Med Genet Date: 2001-01 Impact factor: 6.318
Authors: Mustafa Tekin; Xia-Juan Xia; Radnaabazar Erdenetungalag; Filiz Basak Cengiz; Thomas W White; Janchiv Radnaabazar; Begzsuren Dangaasuren; Hakki Tastan; Walter E Nance; Arti Pandya Journal: Ann Hum Genet Date: 2010-01-27 Impact factor: 1.670
Authors: O Uyguner; M Emiroglu; A Uzumcu; G Hafiz; A Ghanbari; N Baserer; M Yuksel-Apak; B Wollnik Journal: Clin Genet Date: 2003-07 Impact factor: 4.438
Authors: Aslı Subaşıoğlu; Duygu Duman; Aslı Sırmacı; Güney Bademci; Fehime Carkıt; Mehmet Akif Somdaş; Mustafa Erkan; Mustafa Tekin; Munis Dündar Journal: Turk Pediatri Ars Date: 2017-09-01
Authors: So Young Kim; Ah Reum Kim; Nayoung K D Kim; Chung Lee; Min Young Kim; Eun-Hee Jeon; Woong-Yang Park; Byung Yoon Choi Journal: Medicine (Baltimore) Date: 2016-04 Impact factor: 1.889
Authors: Marina V Zytsar; Marita S Bady-Khoo; Valeriia Yu Danilchenko; Ekaterina A Maslova; Nikolay A Barashkov; Igor V Morozov; Alexander A Bondar; Olga L Posukh Journal: Genes (Basel) Date: 2020-07-21 Impact factor: 4.096
Authors: T D Matos; H Simões-Teixeira; H Caria; R Cascão; H Rosa; A O'Neill; O Dias; M E Andrea; D P Kelsell; G Fialho Journal: Genet Res Int Date: 2011-10-05
Authors: Marta Gandía; Francisco J Del Castillo; Francisco J Rodríguez-Álvarez; Gema Garrido; Manuela Villamar; Manuela Calderón; Miguel A Moreno-Pelayo; Felipe Moreno; Ignacio del Castillo Journal: PLoS One Date: 2013-09-06 Impact factor: 3.240